Gufic Biosciences Ltd (BOM:509079)

Q1 2026 Gufic Biosciences Ltd Earnings Call Transcript

Aug 14, 2025 / 06:30 AM GMT

Release Date Price: ₹355.65 (-0.03%)

Transcript

Key Points

Positve

Gufic Biosciences Ltd (BOM:509079) has successfully initiated operations at its advanced Indore facility, which meets global standards including WHO GMP and US FDA.
The company has secured 145 state FDA approvals and completed tech transfers for several injectable products, enhancing its product pipeline.
There is a strategic focus on high-margin segments such as critical care and reproductive medicine, with new product launches targeting resistant pathogens and specific patient segments.
The company is expanding its aesthetic portfolio with potential in-licensing deals for fillers and bio-stimulators, aiming to strengthen its market position.
Gufic Biosciences Ltd (BOM:509079) has shown a 10% revenue growth this quarter, attributed to the new Indore facility and stabilization in critical care pricing.

Negative

The company faces challenges with cash flow conversion, partly due to extended payment cycles post-COVID, impacting working capital.
There is a delay in achieving full capacity utilization at the Indore plant, which affects the timeline for realizing expected revenue growth.
Price erosion in critical care products has been a concern, although it has stabilized recently.
The company anticipates margin pressure in the near term due to the ramp-up phase of the Indore facility.
Export growth is contingent on regulatory approvals, which introduces uncertainty in the timeline for capturing international market share.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GUFI.NS - Gufic Biosciences Ltd
Q1 2026 Gufic Biosciences Ltd Earnings Call
Aug 14, 2025 / 06:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day and welcome to Goofi Biosciences Limited investor calls for Q12526.

As a reminder, all participant lines will be in the listen-only mode, and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing and then 0 on your touchtone phone.

Please note that this conference is being recorded.

I now have the conference over to Ms. Aisha.

Thank you and over to you, ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
---------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.